Find Your Funding Opportunity
Notice of Intent to Publish a Funding Opportunity Announcement for Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
04-29-2024 | $25.0 M | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Expected Number of Awards 4
- Opportunity Type Discretionary
-
CFDA
93.855 -- Allergy and Infectious Diseases Research
Description
The National Institute of Allergy and Infectious Diseases intends to publish a Notice of Funding Opportunity (NOFO) to solicit�applications from single institutions or a consortium of institutions to participate in the Centers for Excellence in Translational Research (CETR) program. This cooperative agreement program will support multidisciplinary translational research Centers focused on generating, validating, and advancing medical countermeasures against bacteria and/or fungi that have known and emerging resistance to current therapies. Pathogens of interest for the NOFO will be a subset of the 2019 CDC Report on Antibiotic Resistance Threats in the US,�https://www.cdc.gov/drugresistance/biggest-threats.html. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in winter 2023 with an expected application due date in spring 2024. This NOFO will utilize the U19 activity code. Details of the planned NOFO are provided below.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- October 23, 2023: Forecasted Date
- December 29, 2023: Estimated Post Date
- April 29, 2024: Estimated Application Due Date
- March 01, 2025: Estimated Project Start Date
- March 01, 2025: Estimated Award Date